Volume | 173,143 |
|
|||||
News | (1) | ||||||
Day High | 0.9631 | Low High |
|||||
Day Low | 0.89 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Rapid Micro Biosystems Inc | RPID | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.935 | 0.89 | 0.9631 | 0.89 | 0.99 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
421 | 173,143 | US$ 0.9187455 | US$ 159,074 | - | 0.74 - 1.19 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:45:34 | formt | 1,309 | US$ 0.91 | USD |
Rapid Micro Biosystems Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
38.25M | 42.50M | - | 22.52M | -52.47M | -1.23 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Rapid Micro Biosystems News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RPID Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.95 | 0.99 | 0.89 | 0.9511878 | 45,532 | -0.04 | -4.21% |
1 Month | 0.98 | 1.02 | 0.84 | 0.9382938 | 39,152 | -0.07 | -7.14% |
3 Months | 0.96 | 1.15 | 0.84 | 0.9713802 | 39,817 | -0.05 | -5.21% |
6 Months | 1.03 | 1.18 | 0.74 | 0.9554996 | 126,942 | -0.12 | -11.65% |
1 Year | 0.98 | 1.19 | 0.74 | 0.9648521 | 81,994 | -0.07 | -7.14% |
3 Years | 22.50 | 27.04 | 0.74 | 7.00 | 127,767 | -21.59 | -95.96% |
5 Years | 22.50 | 27.04 | 0.74 | 7.00 | 127,767 | -21.59 | -95.96% |
Rapid Micro Biosystems Description
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services. |